These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Antithrombotic therapy for acute myocardial infarction: mechanisms and prevention of deep venous, left ventricular, and coronary artery thromboembolism. Chesebro JH; Fuster V Circulation; 1986 Nov; 74(5 Pt 2):III1-10. PubMed ID: 3533316 [No Abstract] [Full Text] [Related]
43. [Anticoagulants in coronary disease]. Popescu P Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1976; 28(5):329-34. PubMed ID: 14368 [No Abstract] [Full Text] [Related]
44. [Thrombosis in unstable angina. Is there a role for thrombolytic agents?]. Raynaud P; Desveaux B; Pacouret G Ann Cardiol Angeiol (Paris); 1989 Sep; 38(7):425-30. PubMed ID: 2686522 [TBL] [Abstract][Full Text] [Related]
45. Influence of selective endoperoxide/thromboxane A2 receptor antagonism with sulotroban on lysis time and reocclusion rate after tissue plasminogen activator-induced coronary thrombolysis in the dog. Shebuski RJ; Smith JM; Storer BL; Granett JR; Bugelski PJ J Pharmacol Exp Ther; 1988 Aug; 246(2):790-6. PubMed ID: 3136245 [TBL] [Abstract][Full Text] [Related]
47. Factors contributing to the emergence of coronary thrombolysis. Tiefenbrunn AJ; Sobel BE Cardiol Clin; 1987 Feb; 5(1):49-53. PubMed ID: 3103920 [TBL] [Abstract][Full Text] [Related]
48. [Fibrinolytic chemotherapy. First report of a personal experience]. Perrin A; Fontaine L; Saint-Pierre A Sem Ther; 1964 Oct; 40(8):476-8. PubMed ID: 5878570 [No Abstract] [Full Text] [Related]
50. [Thrombolytic therapy in myocardial infarct and its assumptions. Experiences of the Italian Group for the Study of Streptokinase in Myocardial Infarct]. G Ital Cardiol; 1987 Jan; 17(1):9-13. PubMed ID: 3552844 [No Abstract] [Full Text] [Related]
51. [Invasive and antithrombotic therapy for coronary ectasia with high intracoronary thrombus burden: two cases report]. Leng WX; Li XD; Liu XN; Gao Z; Song L; Zhang Y; Gao LJ; Chen J; Yuan JQ Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Sep; 47(9):745-747. PubMed ID: 31550848 [TBL] [Abstract][Full Text] [Related]
52. [Antithrombotic therapy in cardiac disease: approach for the selection of pharmacologic agents]. Fuster V Rev Esp Cardiol; 1988 Dec; 41(10):579-85. PubMed ID: 2976966 [No Abstract] [Full Text] [Related]
53. [Therapy of coronary arteriosclerosis and its complications]. Giordano MP; Allegri M Clin Ter; 1972 Feb; 60(3):259-74. PubMed ID: 4665993 [No Abstract] [Full Text] [Related]
54. Triple antithrombotic management after stent implantation: when and how? Schömig A; Sarafoff N; Seyfarth M Heart; 2009 Aug; 95(15):1280-5. PubMed ID: 19605755 [No Abstract] [Full Text] [Related]
56. Long-term induction of fibrinolytic activity in chronic arterial vessel disease. van de Loo JC Adv Exp Med Biol; 1984; 164():251-4. PubMed ID: 6695574 [No Abstract] [Full Text] [Related]